Madrigal Pharmaceuticals (MDGL) Competitor Comparison
We are evaluating the key criteria listed to compare Madrigal Pharmaceuticals (MDGL) against its competitors in the Biotechnology industry.
Market Capitalization
36 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
310 / 337Free Cashflow
322 / 352Quick Ratio
277 / 357Earnings per Share
353 / 359Dividend yield
0 / 6Total Cash
138 / 358Performance 3 years
16 / 368Performance 5 years
36 / 368Performance 10 years
40 / 368Linearity 3 years
356 / 368Linearity 5 years
349 / 368Linearity 10 years
355 / 368Total Rank
332 / 368Dividend Rank
195 / 368Valuation Rank
354 / 368Piotroski Rank
186 / 368Muliplier Rank
148 / 368Total Revenue - MDGL ranking 0 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.